NCT00525044View on ClinicalTrials.gov

Double-blind Trial to Investigate Efficacy and Tolerance of Ambroxol Lozenges 20 mg in Sore Throat

PHASE3CompletedINTERVENTIONAL
Enrollment

249

Participants

Timeline

Start Date

August 1, 2007

Primary Completion Date

January 1, 2008

Study Completion Date

January 1, 2008

Conditions
Pharyngitis
Interventions
DRUG

Ambroxol

DRUG

Placebo

Trial Locations (4)

Unknown

Boehringer Ingelheim Investigational Site, Nanjing

Boehringer Ingelheim Investigational Site, Shanghai

ENT Subsidiary of Fudan University Hospital, Shanghai

Boehringer Ingelheim Investigational Site, Wuhan

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT00525044 - Double-blind Trial to Investigate Efficacy and Tolerance of Ambroxol Lozenges 20 mg in Sore Throat | Biotech Hunter | Biotech Hunter